Home > Publikationen > Publikationen & Wissenschaft

Publikationen & Wissenschaft

Alle Einträge

Die 20 aktuellsten Einträge zeigen

  • 05. April 2021 - Asian J Androl
    Vomstein K, Reiser E, Pinggera GM, Toerzsoek P, Deininger S, Kriesche T, Biasio W, Lusuardi L, Toth B
    Sperm banking before gonadotoxic treatment: is it worth the effort?
    Zeige auf PubMed

  • 02. April 2021 - Oncogene
    Puhr M, Eigentler A, Handle F, Hackl H, Ploner C, Heidegger I, Schaefer G, Brandt MP, Hoefer J, Van der Pluijm G, Klocker H
    Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 22. März 2021 - Ther Adv Urol
    D'Elia C, Folchini DM, Mian C, Hanspeter E, Schwienbacher C, Spedicato GA, Pycha S, Vjaters E, Degener S, Kafka M, Pycha A, Trenti E
    Diagnostic value of Xpert<sup>®</sup> Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update.
    Zeige auf PubMed
    Zum pdf

  • 13. März 2021 - J Nucl Med
    Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka H, Decristoforo C, von Guggenberg E, Horninger W, Virgolini IJ
    Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for <sup>68</sup>Ga-PSMA-11 PET/CT.
    Zeige auf PubMed
    Zum pdf

  • 11. März 2021 - J Pediatr Urol
    Silay MS, 't Hoen L, Bhatt N, Quaedackers J, Bogaert G, Dogan HS, Nijman RJM, Rawashdeh Y, Stein R, Tekgul S, Radmayr C
    Are there any benefits of using an inlay graft in the treatment of primary hypospadias in children? A systematic review and metanalysis.
    Zeige auf PubMed
    Zum pdf

  • 11. März 2021 - Am J Pathol
    Furlan T, Kirchmair A, Sampson N, Puhr M, Gruber M, Trajanoski Z, Santer FR, Parson W, Handle F, Culig Z
    MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.
    Zeige auf PubMed
    Zum pdf

  • 06. März 2021 - J Clin Med
    Pichler R, Lindner AK, Schäfer G, Tulchiner G, Staudacher N, Mayr M, Comperat E, Orme JJ, Schachtner G, Thurnher M
    Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study.
    Zeige auf PubMed
    Zum pdf

  • 01. März 2021 - Cancer Immunol Immunother
    Tulchiner G, Pichler R, Ulmer H, Staudacher N, Lindner AK, Brunner A, Zelger B, Steinkohl F, Aigner F, Horninger W, Thurnher M
    Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 16. Februar 2021 - J Pediatr Urol
    't Hoen LA, Bogaert G, Radmayr C, Dogan HS, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Bhatt NR, Stein R
    Update of the EAU/ESPU guidelines on urinary tract infections in children.
    Zeige auf PubMed
    Zum pdf

  • 15. Februar 2021 - Hypertension
    Vlahou A, Hallinan D, Apweiler R, Argiles A, Beige J, Benigni A, Bischoff R, Black PC, Boehm F, Céraline J, Chrousos GP, Delles C, Evenepoel P, Fridolin I, Glorieux G, van Gool AJ, Heidegger I, Ioannidis JPA, Jankowski J, Jankowski V, Jeronimo C, Kamat AM, Masereeuw R, Mayer G, Mischak H, Ortiz A, Remuzzi G, Rossing P, Schanstra JP, Schmitz-Dräger BJ, Spasovski G, Staessen JA, Stamatialis D, Stenvinkel P, Wanner C, Williams SB, Zannad F, Zoccali C, Vanholder R
    Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?
    Zeige auf PubMed
    Zum pdf

  • 11. Februar 2021 - Transl Lung Cancer Res
    Kocher F, Amann A, Zimmer K, Geisler S, Fuchs D, Pichler R, Wolf D, Kurz K, Seeber A, Pircher A
    High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC).
    Zeige auf PubMed
    Zum pdf

  • 10. Februar 2021 - N Engl J Med
    Pircher A, Heidegger I, Wolf D
    Atezolizumab for PD-L1-Selected Patients with NSCLC.
    Zeige auf PubMed
    Zum pdf

  • 31. Jänner 2021 - Urol Int
    Mumm JN, Klehr B, Rodler S, Kretschmer A, Vilsmaier T, Westhofen T, Chaloupka M, Schulz GB, Gozzi C, Rehder P, May F, Homberg R, Stief CG, Grabbert M, Bauer RM
    Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors.
    Zeige auf PubMed
    Zum pdf

  • 19. Jänner 2021 - Br J Pharmacol
    Gruenbacher G, Gander H, Dobler G, Rahm A, Klaver D, Thurnher M
    The human G protein-coupled ATP receptor P2Y<sub>11</sub> is a target for anti-inflammatory strategies.
    Zeige auf PubMed
    Zum pdf

  • 17. Jänner 2021 - BJU Int
    Tulchiner G, Brunner A, Schmidinger M, Staudacher N, Orme JJ, Thurnher M, Horninger W, Culig Z, Pichler R
    CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 12. Jänner 2021 - Int J Mol Sci
    Lindner AK, Schachtner G, Tulchiner G, Thurnher M, Untergasser G, Obrist P, Pipp I, Steinkohl F, Horninger W, Culig Z, Pichler R
    Lynch Syndrome: Its Impact on Urothelial Carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 10. Jänner 2021 - Eur Urol Oncol
    Steuber T, Heidegger I, Kafka M, Roeder MA, Chun F, Preisser F, Palisaar RJ, Hanske J, Budaeus L, Schiess R, Keller T, Semjonow A, Hammerer P, Manka L, Ecke T, Schwentner C, Ohlmann C
    PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 09. Jänner 2021 - Anticancer Res
    KÖditz B, Stog A, GÖbel H, Heidegger I, Fries J, Heidenreich A, VON Brandenstein M
    Vimentin 3 Expression in Prostate Cancer Cells.
    Zeige auf PubMed
    Zum pdf

  • 07. Jänner 2021 - Urol Int
    Kliesch S, Schmidt S, Wilborn D, Aigner C, Albrecht W, Bedke J, Beintker M, Beyersdorff D, Bokemeyer C, Busch J, Classen J, de Wit M, Dieckmann KP, Diemer T, Dieing A, Gockel M, Göckel-Beining B, Hakenberg OW, Heidenreich A, Heinzelbecker J, Herkommer K, Hermanns T, Kaufmann S, Kornmann M, Kotzerke J, Krege S, Kristiansen G, Lorch A, Müller AC, Oechsle K, Ohloff T, Oing C, Otto U, Pfister D, Pichler R, Recken H, Rick O, Rudolph Y, Ruf C, Schirren J, Schmelz H, Schmidberger H, Schrader M, Schweyer S, Seeling S, Souchon R, Winter C, Wittekind C, Zengerling F, Zermann DH, Zillmann R, Albers P
    Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
    Zeige auf PubMed
    Zum pdf

  • 29. Dezember 2020 - Hum Reprod
    Rudnik-Schöneborn S, Messner M, Vockel M, Wirleitner B, Pinggera GM, Witsch-Baumgartner M, Murtinger M, Kliesch S, Swoboda M, Sänger N, Zschocke J, Tüttelmann F
    Andrological findings in infertile men with two (biallelic) CFTR mutations: results of a multicentre study in Germany and Austria comprising 71 patients.
    Zeige auf PubMed

  • 04. Dezember 2020 - Macromol Biosci
    Wurm F, Pinggera GM, Pham T, Bechtold T
    Investigation on the Behavior of κ -Carrageenan Hydrogels for Compressive Intra-Vessel Disintegration.
    Zeige auf PubMed
    Zum pdf

  • 27. November 2020 - Eur Urol Oncol
    Heidegger I, Necchi A, Pircher A, Tsaur I, Marra G, Kasivisvanathan V, Kretschmer A, Mathieu R, Ceci F, van den Bergh RCN, Thibault C, Tilki D, Valerio M, Surcel C, Gandaglia G, EAU-YAU Prostate Cancer Working Party.
    A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
    Zeige auf PubMed
    Zum pdf

  • 11. November 2020 - Cancers (Basel)
    Heidegger I
    Recent Scientific Developments in Metastatic Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 05. November 2020 - Cancers (Basel)
    Muresan XM, Bouchal J, Culig Z, Souček K
    Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance.
    Zeige auf PubMed
    Zum pdf

  • 02. November 2020 - World J Urol
    Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A, as part of the EAU-YAU PCa Working Party.
    Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 20. Oktober 2020 - Cancers (Basel)
    Bertok T, Jane E, Bertokova A, Lorencova L, Zvara P, Smolkova B, Kucera R, Klocker H, Tkac J
    Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies.
    Zeige auf PubMed
    Zum pdf

  • 13. Oktober 2020 - Urologe A
    Kunz Y, Horninger W, Pinggera GM
    [What should urologists know about SARS-CoV-2? Risk analysis for urological operations and recommendations for action in clinical routine].
    Zeige auf PubMed
    Zum pdf

  • 09. Oktober 2020 - Int J Cancer
    Aksoy O, Pencik J, Hartenbach M, Moazzami AA, Schlederer M, Balber T, Varady A, Philippe C, Baltzer PA, Mazumder B, Whitchurch JB, Roberts CJ, Haitel A, Herac M, Susani M, Mitterhauser M, Marculescu R, Stangl-Kremser J, Hassler MR, Kramer G, Shariat SF, Turner SD, Tichy B, Oppelt J, Pospisilova S, Hartenbach S, Tangermann S, Egger G, Neubauer HA, Moriggl R, Culig Z, Greiner G, Hoermann G, Hacker M, Heery DM, Merkel O, Kenner L
    Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 30. September 2020 - Cancers (Basel)
    Pichler R
    Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers.
    Zeige auf PubMed
    Zum pdf

  • 23. September 2020 - Eur Urol Focus
    Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, van den Bergh RCN, Valerio M, Marra G, Kasivisvanathan V, Buchner A, Stief CG, Briganti A, Montorsi F, Tilki D, Gandaglia G, EAU-YAU Prostate Cancer Working Party.
    Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.
    Zeige auf PubMed
    Zum pdf

  • 16. September 2020 - Eur Urol Oncol
    Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F, Ploussard G, van den Bergh RCN, Kretschmer A, Thibault C, Ost P, Tilki D, Kasivisvanathan V, Moschini M, Sanchez-Salas R, Gontero P, Karnes RJ, Montorsi F, Gandaglia G, EAU-YAU Prostate Cancer Working Party.
    Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
    Zeige auf PubMed
    Zum pdf

  • 12. September 2020 - J Clin Med
    Staudacher N, Tulchiner G, Bates K, Ladurner M, Kafka M, Aigner F, Pichler R, Horninger W
    Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?
    Zeige auf PubMed
    Zum pdf

  • 27. August 2020 - N Engl J Med
    Heidegger I, Pircher A
    Olaparib for Metastatic Castration-Resistant Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 14. August 2020 - PLoS One
    Erb HHH, Bodenbender J, Handle F, Diehl T, Donix L, Tsaur I, Gleave M, Haferkamp A, Huber J, Fuessel S, Juengel E, Culig Z, Thomas C
    Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 01. August 2020 - Cancers (Basel)
    Kafka M, Mayr F, Temml V, Möller G, Adamski J, Höfer J, Schwaiger S, Heidegger I, Matuszczak B, Schuster D, Klocker H, Bektic J, Stuppner H, Eder IE
    Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 26. Juli 2020 - Cancers (Basel)
    Fendt L, Fazzini F, Weissensteiner H, Bruckmoser E, Schönherr S, Schäfer G, Losso JL, Streiter GA, Lamina C, Rasse M, Klocker H, Kofler B, Kloss-Brandstätter A, Huck CW, Kronenberg F, Laimer J
    Profiling of Mitochondrial DNA Heteroplasmy in a Prospective Oral Squamous Cell Carcinoma Study.
    Zeige auf PubMed
    Zum pdf

  • 13. Juli 2020 - Eur Urol Focus
    Tsaur I, Heidegger I, van den Bergh RCN, Bektic J, Borgmann H, Foti S, Hunting JCB, Kretschmer A, Ploussard G, Tilki D, Gandaglia G, Dotzauer R, EAU-YAU Prostate Cancer Working Party.
    Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
    Zeige auf PubMed
    Zum pdf

  • 29. Juni 2020 - Liver Transpl
    Paine CH, Pichler RH
    Intraoperative Renal Replacement Therapy for Liver Transplantation: Is There Really a Benefit?
    Zeige auf PubMed
    Zum pdf

  • 28. Juni 2020 - Urol Oncol
    Kafka M, Eder IE, Klocker H, Heidegger I
    Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 25. Juni 2020 - Mol Oncol
    Drápela S, Khirsariya P, van Weerden WM, Fedr R, Suchánková T, Búzová D, Červený J, Hampl A, Puhr M, Watson WR, Culig Z, Krejčí L, Paruch K, Souček K
    The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.
    Zeige auf PubMed
    Zum pdf

  • 21. Juni 2020 - BJU Int
    Kunz Y, Horninger W, Pinggera GM
    Are urologists in trouble with SARS-CoV-2? Reflections and recommendations for specific interventions.
    Zeige auf PubMed
    Zum pdf

  • 21. Juni 2020 - Urologe A
    Köhn FM, Kliesch S, Pinggera GM, Schuppe HC, Tüttelmann F
    [Andrological diagnostics prior to treatment by assisted reproduction].
    Zeige auf PubMed
    Zum pdf

  • 04. Juni 2020 - Urol Case Rep
    Rehder P, Pedrini M, Jelisejevas LA, Gulacsi A, Horninger W, Stuehmeier J
    Urethro-cavernosal-spongiosal fistula after intralesional mitomycin C for recurrent urethral stricture disease.
    Zeige auf PubMed
    Zum pdf

  • 04. Juni 2020 - Urol Case Rep
    Rehder P, Barkhuizen M, Redecker A, Oeconomou A, Madersbacher H, Stuehmeier J
    Salvage perineal-retropubic AUS cuff in paraplegic patient with exstrophy-epispadias complex after previous cuff erosion at bladder neck.
    Zeige auf PubMed
    Zum pdf

  • 04. Juni 2020 - Urol Case Rep
    Kivi M, Ahlberg A, Okas R, Stuehmeier J, Pedrini M, Rehder P
    Female urethral avulsion and bladder neck closure: What now? Trigonal tubularization with placement of an artificial urinary sphincter.
    Zeige auf PubMed
    Zum pdf

  • 31. Mai 2020 - Eur J Pediatr
    Tekgul S, Stein R, Bogaert G, Undre S, Nijman RJM, Quaedackers J, 't Hoen L, Kocvara R, Silay MS, Radmayr C, Dogan HS
    EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children.
    Zeige auf PubMed
    Zum pdf

  • 20. Mai 2020 - Urol Case Rep
    Pedrini M, Stuehmeier J, Jelisejevas LA, Gulacsi A, Horninger W, Rehder P
    Excessive fibrosis and non-function after ATOMS (adjustable transobturator male system): A case of capsular contracture?
    Zeige auf PubMed
    Zum pdf

  • 20. Mai 2020 - Urol Case Rep
    Rehder P, Stuehmeier J, Jelisejevas LA, Gulacsi A, Horninger W, Pedrini M
    World record: Single AMS 800 artificial urinary sphincter functioning uninterrupted for 29 years in male paraplegic patient.
    Zeige auf PubMed
    Zum pdf

  • 14. Mai 2020 - Cancers (Basel)
    Seles M, Hutterer GC, Foßelteder J, Svoboda M, Resel M, Barth DA, Pichler R, Bauernhofer T, Zigeuner RE, Pummer K, Slaby O, Klec C, Pichler M
    Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
    Zeige auf PubMed
    Zum pdf

  • 10. Mai 2020 - Eur J Nucl Med Mol Imaging
    Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka A, Decristoforo C, di Santo G, von Guggenberg E, Horninger W, Virgolini IJ
    Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
    Zeige auf PubMed
    Zum pdf

  • 08. Mai 2020 - Eur Urol
    Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, Harding C, Breda A, Bex A, GORRG Group., Rassweiler JJ, Gözen AS, Pini G, Liatsikos E, Giannarini G, Mottrie A, Subramaniam R, Sofikitis N, Rocco BMC, Xie LP, Witjes JA, Mottet N, Ljungberg B, Rouprêt M, Laguna MP, Salonia A, Bonkat G, Blok BFM, Türk C, Radmayr C, Kitrey ND, Engeler DS, Lumen N, Hakenberg OW, Watkin N, Hamid R, Olsburgh J, Darraugh J, Shepherd R, Smith EJ, Chapple CR, Stenzl A, Van Poppel H, Wirth M, Sønksen J, N'Dow J, EAU Section Offices and the EAU Guidelines Panels.
    European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era.
    Zeige auf PubMed
    Zum pdf

  • 07. Mai 2020 - Urol Case Rep
    Rehder P, Jelisejevas LA, Pedrini M, Gulacsi A, Horninger W, Stuehmeier J
    Intrapelvic bulboprostatic repair after urethral distraction injury and failed bulbomembranous anastomosis.
    Zeige auf PubMed
    Zum pdf

  • 06. Mai 2020 - Anticancer Res
    Kafka M, Strohhacker K, Aigner F, Steinkohl F, Horninger W, Pichler R, Heidegger I
    Incidental Testicular Pathologies in Patients With Idiopathic Hydrocele Testis: Is Preoperative Scrotal Ultrasound Justified?
    Zeige auf PubMed
    Zum pdf

  • 16. April 2020 - J Pediatr Urol
    Quaedackers JSLT, Stein R, Bhatt N, Dogan HS, Hoen L, Nijman RJM, Radmayr C, Silay MS, Tekgul S, Bogaert G
    Clinical and surgical consequences of the COVID-19 pandemic for patients with pediatric urological problems: Statement of the EAU guidelines panel for paediatric urology, March 30 2020.
    Zeige auf PubMed
    Zum pdf

  • 10. April 2020 - Eur Urol
    Gandaglia G, Martini A, Ploussard G, Fossati N, Stabile A, De Visschere P, Borgmann H, Heidegger I, Steinkohl F, Kretschmer A, Marra G, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, Van den Bergh R, Ost P, Gontero P, Montorsi F, Briganti A, EAU-YAU Prostate Cancer Working Group.
    External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Zeige auf PubMed

  • 09. April 2020 - Front Mol Biosci
    Drápela S, Bouchal J, Jolly MK, Culig Z, Souček K
    ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance.
    Zeige auf PubMed
    Zum pdf

  • 03. April 2020 - Cells
    Nussbaumer O, Thurnher M
    Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance.
    Zeige auf PubMed
    Zum pdf

  • 22. März 2020 - Nat Commun
    Schöpf B, Weissensteiner H, Schäfer G, Fazzini F, Charoentong P, Naschberger A, Rupp B, Fendt L, Bukur V, Giese I, Sorn P, Sant'Anna-Silva AC, Iglesias-Gonzalez J, Sahin U, Kronenberg F, Gnaiger E, Klocker H
    OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation.
    Zeige auf PubMed
    Zum pdf

  • 18. März 2020 - Oncotarget
    Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
    The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 12. März 2020
    - BJUI COMPASS Klocker, H., Golding, B., Weber, S., Steiner, E., Tennstedt, P., Keller, T., Schiess, R., Gillessen, S., Horninger, W., and Steuber, T. Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer. https://onlinelibrary.wiley.com/doi/abs/10.1002/bco2.8

  • 18. März 2020 - Oncotarget
    Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
    The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 18. März 2020 - Oncotarget
    Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
    The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 25. Februar 2020 - Eur Urol Focus
    Kretschmer A, Ploussard G, Heidegger I, Tsaur I, Borgmann H, Surcel C, Mathieu R, de Visschere P, Valerio M, van den Bergh RCN, Marra G, Thibault C, Ost P, Gandaglia G, Tilki D, EAU-YAU Prostate Cancer Working Party.
    Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
    Zeige auf PubMed
    Zum pdf

  • 16. Februar 2020 - Cancers (Basel)
    Eigentler A, Tymoszuk P, Zwick J, Schmitz AA, Pircher A, Kocher F, Schlicker A, Lesche R, Schäfer G, Theurl I, Klocker H, Heidegger I
    The Impact of Cand1 in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 05. Februar 2020 - Ann Transl Med
    Pichler R, Schmidinger M
    Can immune biomarkers predict benefit from targeted agents in metastatic renal cell carcinoma?
    Zeige auf PubMed
    Zum pdf

  • 26. Jänner 2020 - Cell Commun Signal
    Neuwirt H, Bouchal J, Kharaishvili G, Ploner C, Jöhrer K, Pitterl F, Weber A, Klocker H, Eder IE
    Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Zeige auf PubMed
    Zum pdf

  • 25. Jänner 2020 - Cancer Cytopathol
    Trenti E, Pycha S, Mian C, Schwienbacher C, Hanspeter E, Kafka M, Spedicato GA, Vjaters E, Degener S, Pycha A, D'Elia C
    Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
    Zeige auf PubMed
    Zum pdf

  • 19. Jänner 2020 - Urol Oncol
    Heidegger I, Brandt MP, Heck MM
    Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?
    Zeige auf PubMed

  • 18. Jänner 2020 - Endocr Relat Cancer
    Gruber M, Ferrone L, Puhr M, Santer FR, Furlan T, Eder IE, Sampson N, Schäfer G, Handle F, Culig Z
    p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 27. Dezember 2019 - Geburtshilfe Frauenheilkd
    Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J
    Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.
    Zeige auf PubMed
    Zum pdf

  • 27. Dezember 2019 - Geburtshilfe Frauenheilkd
    Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J
    Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman.
    Zeige auf PubMed
    Zum pdf

  • 18. Dezember 2019 - Am J Pathol
    Pichler R, Lindner AK, Compérat E, Obrist P, Schäfer G, Todenhöfer T, Horninger W, Culig Z, Untergasser G
    Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Zeige auf PubMed
    Zum pdf

  • 14. Dezember 2019 - Prostate
    Gruber M, Handle F, Culig Z
    The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
    Zeige auf PubMed
    Zum pdf

  • 13. Dezember 2019 - Eur Urol
    Radmayr C
    Re: Cancer Screening in the Pediatric Cancer Patient: A Focus on Genitourinary Malignancies, and Why Does a Urologist Need to Know About This?
    Zeige auf PubMed
    Zum pdf

  • 04. Dezember 2019 - Neurourol Urodyn
    Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C
    EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management.
    Zeige auf PubMed
    Zum pdf

  • 04. Dezember 2019 - Neurourol Urodyn
    Bogaert G, Stein R, Undre S, Nijman RJM, Quadackers J, 't Hoen L, Kocvara R, Silay S, Tekgul S, Radmayr C, Dogan HS
    Practical recommendations of the EAU-ESPU guidelines committee for monosymptomatic enuresis-Bedwetting.
    Zeige auf PubMed
    Zum pdf

  • 29. November 2019 - Eur J Nucl Med Mol Imaging
    Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I
    The <sup>68</sup>Ga/<sup>177</sup>Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
    Zeige auf PubMed
    Zum pdf

  • 30. November 2019 - Cancer Treat Rev
    Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G, EAU-YAU Prostate Cancer Working Party.
    Hereditary prostate cancer - Primetime for genetic testing?
    Zeige auf PubMed
    Zum pdf

  • 15. November 2019 - Neurourol Urodyn
    Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quadackers JSLT, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C
    EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment.
    Zeige auf PubMed
    Zum pdf

  • 04. November 2019 - Clin Genitourin Cancer
    Hebenstreit D, Pichler R, Heidegger I
    Drug-Drug Interactions in Prostate Cancer Treatment.
    Zeige auf PubMed
    Zum pdf

  • 19. Oktober 2019 - BMC Urol
    Rehder P, Rehwald R, Böhm JM, Grams AE, Loizides A, Pedrini M, Stühmeier J, Glodny B
    Supernumerary kidneys: a clinical and radiological analysis of nine cases.
    Zeige auf PubMed
    Zum pdf

  • 16. Oktober 2019 - Urol Int
    D'Elia C, Mian C, Hanspeter E, Ladurner C, Palermo SM, Pycha S, Saleh O, Cai T, Spoladore G, Kafka M, Pycha A, Trenti E
    Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
    Zeige auf PubMed
    Zum pdf

  • 29. August 2019
    - BUCH - Breitenseher Publisher (Verlag) Aigner, F., Pallwein-Prettner, L., and Pinggera, G. Ultraschall des äußeren männlichen Genitals

  • 27. August 2019 - Front Immunol
    Gruenbacher G, Gander H, Rahm A, Dobler G, Drasche A, Troppmair J, Nussbaumer W, Thurnher M
    The Human G Protein-Coupled ATP Receptor P2Y<sub>11</sub> Is Associated With IL-10 Driven Macrophage Differentiation.
    Zeige auf PubMed
    Zum pdf

  • 07. August 2019 - J Clin Med
    Neuwirt H, Leitner-Lechner I, Kerschbaum J, Ertl M, Pöggsteiner F, Pölt N, Mätzler J, Sprenger-Mähr H, Rudnicki M, Schratzberger P, Eder IE, Mayer G
    Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience.
    Zeige auf PubMed
    Zum pdf

  • 13. Juli 2019 - Neurourol Urodyn
    Grabbert M, Mumm JN, Klehr B, Kretschmer A, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Bauer RM
    Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: Results of a prospective and multicenter study.
    Zeige auf PubMed
    Zum pdf

  • 02. Juli 2019 - Front Oncol
    Heidegger I, Pircher A, Pichler R
    Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.
    Zeige auf PubMed
    Zum pdf

  • 26. Juni 2019 - Clin Genitourin Cancer
    Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M
    Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
    Zeige auf PubMed
    Zum pdf

  • 19. Juni 2019 - Urol Case Rep
    Stuehmeier J, Pedrini M, Horninger W, Rehder P
    Preservation of erectile function by artery sparing dilation of the corpora cavernosa in prolonged priapism.
    Zeige auf PubMed
    Zum pdf

  • 03. Juni 2019 - Cancer Cytopathol
    Trenti E, D'Elia C, Mian C, Schwienbacher C, Hanspeter E, Pycha A, Kafka M, Degener S, Danuser H, Roth S, Pycha A
    Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
    Zeige auf PubMed
    Zum pdf

  • 23. Mai 2019 - Curr Radiopharm
    Calabria F, Pichler R, Leporace M, Wolfsgruber J, Coscarelli P, Dunzinger A, Schillaci O, Cascini GL, Bagnato A
    68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.
    Zeige auf PubMed
    Zum pdf

  • 21. Mai 2019 - Biochim Biophys Acta Mol Cell Res
    Culig Z
    Epithelial mesenchymal transition and resistance in endocrine-related cancers.
    Zeige auf PubMed
    Zum pdf

  • 19. Mai 2019 - Neurourol Urodyn
    Dogan HS, Stein R, 't Hoen LA, Bogaert G, Nijman RJM, Tekgul S, Quaedackers J, Silay MS, Radmayr C
    Are EAU/ESPU pediatric urology guideline recommendations on neurogenic bladder well received by the patients? Results of a survey on awareness in spina bifida patients and caregivers.
    Zeige auf PubMed
    Zum pdf

  • 17. Mai 2019 - Br J Cancer
    Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J
    CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 17. Mai 2019 - Br J Cancer
    Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J
    CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 11. Mai 2019 - Eur Urol Focus
    Lindner AK, Gruenbacher G, Schachtner G, Thurnher M, Pichler R
    Rare, but Severe: Vasculitis and Checkpoint Inhibitors.
    Zeige auf PubMed
    Zum pdf

  • 08. Mai 2019 - World J Urol
    Lindner AK, Schachtner G, Steiner E, Kroiss A, Uprimny C, Steinkohl F, Horninger W, Heidegger I, Madersbacher S, Pichler R
    Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.
    Zeige auf PubMed
    Zum pdf

  • 16. April 2019 - Am J Pathol
    Culig Z
    Centrosomal Proteins in Urothelial Tumors: New Pathways in Disease Pathogenesis.
    Zeige auf PubMed
    Zum pdf

  • 04. April 2019 - Gerontology
    Madersbacher S, Sampson N, Culig Z
    Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
    Zeige auf PubMed
    Zum pdf

  • 03. April 2019 - Cancers (Basel)
    Pichler R, Compérat E, Klatte T, Pichler M, Loidl W, Lusuardi L, Schmidinger M
    Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
    Zeige auf PubMed
    Zum pdf

  • 02. April 2019 - Front Pediatr
    Tonnhofer U, Hiess M, Metzelder M, Hebenstreit D, Springer A
    Midline Incision of a Graft in Staged Hypospadias Repair-Feasible and Durable?
    Zeige auf PubMed
    Zum pdf

  • 16. März 2019 - J Clin Oncol
    Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G
    Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Zeige auf PubMed

  • 16. März 2019 - Cancer Treat Rev
    Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C, EAU-YAU Prostate Cancer Working Party.
    Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
    Zeige auf PubMed
    Zum pdf

  • 01. März 2019 - Tumour Biol
    Degasper C, Brunner A, Sampson N, Tsibulak I, Wieser V, Welponer H, Marth C, Fiegl H, Zeimet AG
    NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.
    Zeige auf PubMed
    Zum pdf

  • 27. Februar 2019 - Eur Urol
    Pichler R, Heidegger I
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol 2019;75:853-60.
    Zeige auf PubMed
    Zum pdf

  • 09. Jänner 2019 - Eur Urol
    Heidegger I, Pichler R
    Re: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019;75:558-61.
    Zeige auf PubMed
    Zum pdf

  • 01. Jänner 2019 - Memo
    Steinkohl F, Pichler R, Junker D
    Short review of biparametric prostate MRI.
    Zeige auf PubMed
    Zum pdf

  • 01. Jänner 2019 - Memo
    Pichler R, Horninger W, Heidegger I
    ASCO 2018: highlights of urothelial cancer and prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 28. Dezember 2018 - In Vivo
    Auer T, Heidegger I, DE Zordo T, Junker D, Jaschke W, Steinkohl F, Aigner F
    Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions.
    Zeige auf PubMed
    Zum pdf

  • 15. Dezember 2018 - World J Urol
    Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, Hellmich M, Pfister D, Heidenreich A
    Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
    Zeige auf PubMed
    Zum pdf

  • 14. Dezember 2018
    - EUR SURG Kafka, M., Rehder, P., Maier, H., and Horninger, W. Incidental resetion of a scrotal aggressive angiomyxoma mimiking a permatocele: a case report.

  • 13. Dezember 2018 - Oxid Med Cell Longev
    Feichtinger RG, Schäfer G, Seifarth C, Mayr JA, Kofler B, Klocker H
    Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 12. Dezember 2018 - Med Ultrason
    Steinkohl F, Luger AK, Pichler R, Bektic J, Rehder P, Lebovici A, Aigner F
    Visibility of MRI prostate lesions on B-mode transrectal ultrasound.
    Zeige auf PubMed
    Zum pdf

  • 13. November 2018 - Eur Urol
    Radmayr C
    Re: Clinical Outcomes of the Upper Urinary Tract after Ureteral Clipping for Treatment of Low Functioning or Nonfunctioning Renal Moieties.
    Zeige auf PubMed
    Zum pdf

  • 05. November 2018 - Eur Urol
    Ploussard G, Gandaglia G, Borgmann H, de Visschere P, Heidegger I, Kretschmer A, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, Ost P, Briganti A, EAU-YAU Prostate Cancer Working Group.
    Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
    Zeige auf PubMed
    Zum pdf

  • 15. Oktober 2018 - Eur Urol
    Silay MS, Hoen L, Quadackaers J, Undre S, Bogaert G, Dogan HS, Kocvara R, Nijman RJM, Radmayr C, Tekgul S, Stein R
    Treatment of Varicocele in Children and Adolescents: A Systematic Review and Meta-analysis from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel.
    Zeige auf PubMed
    Zum pdf

  • 10. Oktober 2018 - Front Oncol
    Gruenbacher G, Thurnher M
    Mevalonate Metabolism in Cancer Stemness and Trained Immunity.
    Zeige auf PubMed
    Zum pdf

  • 09. Oktober 2018 - Eur Urol
    Culig Z
    Identification of Potential Novel Candidates for Understanding Racial Differences in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. Oktober 2018
    - N. Sampson. ARTP Award 2018 of the European Society for Urological Research for Cancer -associated fibroblast heterogeneity within the prostate cancer stromal microinvironment.
    Weitere Infos zur Publikation

  • 01. Oktober 2018 - Urol Oncol
    Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Mirvald C, Gandaglia G, Briganti A, van den Bergh R, Tilki D, Ost P, Ploussard G, Surcel C, EAU-YAU Prostate Cancer Working Party.
    Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update.
    Zeige auf PubMed
    Zum pdf

  • 28. September 2018
    - M. Puhr. Science and Innovation Prize 2018 of the German Society of Urology (DGU) for the paper: The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clin Cancer Res, 2018 24:927-938.
    Weitere Infos zur Publikation

  • 27. September 2018 - Mol Cancer Ther
    Handle F, Puhr M, Schaefer G, Lorito N, Hoefer J, Gruber M, Guggenberger F, Santer FR, Marques RB, van Weerden WM, Claessens F, Erb HHH, Culig Z
    The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
    Zeige auf PubMed
    Zum pdf

  • 17. September 2018 - Pathol Oncol Res
    Fucic A, Aghajanyan A, Culig Z, Le Novere N
    Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. September 2018 - Aktuelle Urol
    Heidegger I, Steinkohl F, Horninger W, Pichler R
    [Symptomatic urinary obstruction in patients with metastatic malignancies].
    Zeige auf PubMed
    Zum pdf

  • 23. August 2018 - BJU Int
    Culig Z
    The way towards understanding possible multiple functions of AR V7 in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. August 2018 - World J Urol
    Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, Herrmann TRW, Rieger M, Nagele U
    Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
    Zeige auf PubMed
    Zum pdf

  • 04. August 2018 - Prostate
    Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, Nguyen HM, Culig Z, van der Pluijm G, Rentsch CA, Marques RB, de Ridder CMA, Bubendorf L, Thalmann GN, Brennen WN, Santer FR, Moser PL, Shepherd P, Efstathiou E, Xue H, Lin D, Buijs J, Bosse T, Collins A, Maitland N, Buzza M, Kouspou M, Achtman A, Taylor RA, Risbridger G, Corey E
    Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Zeige auf PubMed
    Zum pdf

  • 02. August 2018
    - A. Pircher, M. Zieher, A. Eigentler, R. Pichler, G. Schafer, J. Fritz, M. Puhr, E. Steiner, W. Horninger, H. Klocker and I. Heidegger....Antidiabetic drugs influence molecular mechanisms in prostate cancer.

  • 26. Juli 2018 - Rev Esp Med Nucl Imagen Mol (Engl Ed)
    Kroiss AS, Uprimny C, Pichler R, Gasser RW, Virgolini IJ
    A rare case of a <sup>123</sup>I-MIBG SPECT/CT positive, but <sup>68</sup>Ga-DOTA-TOC PET/CT negative pheochromocytoma of the bladder.
    Zeige auf PubMed
    Zum pdf

  • 25. Juli 2018 - Int J Mol Sci
    Weber A, Klocker H, Oberacher H, Gnaiger E, Neuwirt H, Sampson N, Eder IE
    Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells.
    Zeige auf PubMed
    Zum pdf

  • 18. Juli 2018 - Cell Death Dis
    Slabáková E, Culig Z, Remšík J, Souček K
    Correction Alternative mechanisms of miR-34a regulation in cancer.
    Zeige auf PubMed
    Zum pdf

  • 04. Juli 2018 - World J Urol
    Ploussard G, Borgmann H, Briganti A, de Visschere P, Fütterer JJ, Gandaglia G, Heidegger I, Kretschmer A, Mathieu R, Ost P, Sooriakumaran P, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, EAU-YAU Prostate Cancer Working Group.
    Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
    Zeige auf PubMed
    Zum pdf

  • 02. Juli 2018 - Clin Genitourin Cancer
    Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I
    Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.
    Zeige auf PubMed

  • 20. Juni 2018 - Eur Urol
    Guggenberger F, van de Werken HJG, Erb HHH, Cappellano G, Trattnig K, Handle F, Peer S, Schäfer G, Jenster G, Culig Z, Skvortsova I, Santer FR
    Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures.
    Zeige auf PubMed
    Zum pdf

  • 05. Juni 2018 - Aging Male
    Kummer KK, Pope HG, Hudson JI, Kemmler G, Pinggera GM, Mangweth-Matzek B
    Aging male symptomatology and eating behavior.
    Zeige auf PubMed
    Zum pdf

  • 27. Mai 2018 - BJU Int
    Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Csizmarik A, Ristl R, Puhr M, Hoffmann MJ, Niedworok C, Hadaschik B, Maj-Hes A, Shariat SF, Kramer G
    Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 29. Mai 2018
    - I. Heidegger Otto-Kraupp-Preis 2018 für die beste Habilitation, 3. Preis für "Biomarkers and new therapeutic targets in prostate cancer".
    Weitere Infos zur Publikation

  • 23. Mai 2018 - Methods Mol Biol
    Culig Z, Santer FR
    Studies on Steroid Receptor Coactivators in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 17. Mai 2018 - Eur J Nucl Med Mol Imaging
    Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ
    Comparison of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT with [<sup>18</sup>F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
    Zeige auf PubMed
    Zum pdf

  • 08. Mai 2018 - Cent European J Urol
    Lunacek A, Mohamad Al-Ali B, Radmayr C, Weber M, Horninger W, Findl O, Plas E
    Ten years of intraoperative floppy iris syndrome in the era of α-blockers.
    Zeige auf PubMed
    Zum pdf

  • 27. April 2018 - Int J Cancer
    Urbiola C, Santer FR, Petersson M, van der Pluijm G, Horninger W, Erlmann P, Wollmann G, Kimpel J, Culig Z, von Laer D
    Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 18. April 2018 - Int J Rheum Dis
    Moosmann T, Veraar C, Brunner J, Fraedrich G, Frech A, Horninger W, Ratzinger G, Streif W, Teuchner B, Willeit J, Zlamy M, De Zordo T, Schirmer M
    Differential clinical presentation of Adamantiades-Behçet's disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study.
    Zeige auf PubMed
    Zum pdf

  • 13. April 2018 - Transl Androl Urol
    Heidegger I, Pichler R, Heidenreich A, Horninger W, Pircher A
    Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial.
    Zeige auf PubMed
    Zum pdf

  • 17. März 2018
    - I. Eder. Best Abstract Oncology Prize 2018 of the EAU - Third prize for "Upregulation of cholesterol and steroid biosynthesis pathways in prostate cancer cells is associated with diminished response to enzalutamide in a 3-dimensional spheroid co-culture model".
    Weitere Infos zur Publikation

  • 15. März 2018 - Oncotarget
    Lieb V, Weigelt K, Scheinost L, Fischer K, Greither T, Marcou M, Theil G, Klocker H, Holzhausen HJ, Lai X, Vera J, Ekici AB, Horninger W, Fornara P, Wullich B, Taubert H, Wach S
    Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients.
    Zeige auf PubMed
    Zum pdf

  • 03. März 2018 - Cancer Sci
    Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R
    High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 22. Februar 2018 - Mol Oncol
    Feiersinger GE, Trattnig K, Leitner PD, Guggenberger F, Oberhuber A, Peer S, Hermann M, Skvortsova I, Vrbkova J, Bouchal J, Culig Z, Santer FR
    Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
    Zeige auf PubMed
    Zum pdf

  • 15. Februar 2018 - Int J Cancer
    Sampson N, Brunner E, Weber A, Puhr M, Schäfer G, Szyndralewiez C, Klocker H
    Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
    Zeige auf PubMed
    Zum pdf

  • 15. Jänner 2018
    Aigner, F., Pallwein-Pretter, L., Salomon, G., and Horninger, W. Prostata - Multimodale Bildgebung. Zweite erweiterte Auflage, Horn, Austria, Breitenseher Publisher, 2018.

  • 13. Jänner 2018 - Eur J Med Res
    Pichler R, Tulchiner G, Steinkohl F, Soleiman A, Horninger W, Heidegger IM, Aigner F
    Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound.
    Zeige auf PubMed

  • 26. Dezember 2017 - Urol Case Rep
    Pichler R, Heidegger I, Schachtner G, Stuehmeier J, Agaimy A, Maier H, Glodny B, Rehder P
    Renal rupture - Not what it seems.
    Zeige auf PubMed

  • 19. Dezember 2017 - Memo
    Pichler R, Heidegger I
    Novel concepts of antiangiogenic therapies in metastatic renal cell cancer.
    Zeige auf PubMed

  • 19. Dezember 2017 - Front Aging Neurosci
    Hoefer J, Luger M, Dal-Pont C, Culig Z, Schennach H, Jochberger S
    The "Aging Factor" Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor's Age.
    Zeige auf PubMed

  • 19. Dezember 2017 - Memo
    Haidl F, Pfister D, Heidenreich A, Heidegger I
    Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
    Zeige auf PubMed

  • 19. Dezember 2017 - Front Immunol
    Gruenbacher G, Thurnher M
    Mevalonate Metabolism in Immuno-Oncology.
    Zeige auf PubMed

  • 16. Dezember 2017 - World J Urol
    Steinkohl F, Gruber L, Bektic J, Nagele U, Aigner F, Herrmann TRW, Rieger M, Junker D
    Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?
    Zeige auf PubMed

  • 14. Dezember 2017 - J Cell Biochem
    Erb HHH, Guggenberger F, Santer FR, Culig Z
    Interleukin-4 induces a CD44<sub>high</sub> /CD49b<sub>high</sub> PC3 subpopulation with tumor-initiating characteristics.
    Zeige auf PubMed

  • 08. Dezember 2017 - Curr Mol Biol Rep
    Culig Z
    Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 28. November 2017 - Curr Eye Res
    Waltl I, Zehetner C, Seifarth C, Handle F, Kieselbach GF, Angermann R, Kralinger MT
    Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
    Zeige auf PubMed

  • 22. November 2017 - Clin Cancer Res
    Puhr M, Hoefer J, Eigentler A, Ploner C, Handle F, Schaefer G, Kroon J, Leo A, Heidegger I, Eder I, Culig Z, Van der Pluijm G, Klocker H
    The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.
    Zeige auf PubMed

  • 21. November 2017 - J Cancer
    Pichler R, Fritz J, Heidegger I, Oberaigner W, Horninger W, Hochleitner M
    Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.
    Zeige auf PubMed

  • 20. November 2017
    PhD Thesis Medizinische Universität Innsbruck - A. Kohlegger. Perspectives of the chemopreventive effects of natural compoounds in the adjuvant treatment of prostate cancer. Department of Urology, Division of Experimental Urology.

  • 17. November 2017 - Eur J Immunol
    Loeschenberger B, Niess L, Würzner R, Schwelberger H, Eder IE, Puhr M, Guenther J, Troppmair J, Rudnicki M, Neuwirt H
    Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.
    Zeige auf PubMed

  • 11. November 2017 - Oncoimmunology
    Gruenbacher G, Thurnher M
    Mevalonate metabolism governs cancer immune surveillance.
    Zeige auf PubMed

  • 01. November 2017 - Int J Mol Sci
    Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I
    Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.
    Zeige auf PubMed

  • 13. Oktober 2017 - Cell Death Dis
    Slabáková E, Culig Z, Remšík J, Souček K
    Alternative mechanisms of miR-34a regulation in cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. Oktober 2017 - Oncotarget
    Pichler R, Heidegger I, Fritz J, Danzl M, Sprung S, Zelger B, Brunner A, Pircher A
    PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.
    Zeige auf PubMed
    Zum pdf

  • 02. Oktober 2017 - Clin Genitourin Cancer
    Paffenholz P, Heidegger IM, Kuhr K, Loosen SH, Pfister D, Heidenreich A
    Non-Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival.
    Zeige auf PubMed

  • 24. September 2017 - BJU Int
    Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, Klocker H, Heidegger I
    Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Zeige auf PubMed

  • 12. September 2017 - Eur Urol
    Culig Z
    Innovative Therapies to Overcome Resistance to Enzalutamide: Perspective on the Use of Darolutamide.
    Zeige auf PubMed

  • 30. August 2017 - Prostate
    Shi X, Peng Y, Du X, Liu H, Klocker H, Lin Q, Shi J, Zhang J
    Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
    Zeige auf PubMed
    Zum pdf

  • 22. August 2017 - Int J Med Sci
    Pichler R, Tulchiner G, Fritz J, Schaefer G, Horninger W, Heidegger I
    Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Zeige auf PubMed

  • 30. Juli 2017 - Eur Urol Focus
    Radmayr C, Tekgul S
    Paediatric Urology and the Dilemma of Low-quality Evidence for the Management of Common Urological Conditions (Vesicoureteral Reflux, Lower Urinary Tract Dysfunction, Undescended Testis) in Children.
    Zeige auf PubMed

  • 24. Juli 2017 - J Pediatr Urol
    Radmayr C
    Management of undescended testes: European Association of Urology/European Society for Paediatric Urology guidelines.
    Zeige auf PubMed

  • 21. Juli 2017 - Eur Urol Focus
    Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S, Culig Z
    Inflammation, Microbiota, and Prostate Cancer.
    Zeige auf PubMed

  • 21. Juli 2017 - Eur Urol Focus
    Ceder Y, Bjartell A, Culig Z, Rubin MA, Tomlins S, Visakorpi T
    The Molecular Evolution of Castration-resistant Prostate Cancer.
    Zeige auf PubMed

  • 14. Juli 2017 - Radiologe
    Steinkohl F, Luger A, Bektic J, Aigner F
    [Ultrasonography of the prostate gland : From B‑image through multiparametric ultrasound to targeted biopsy].
    Zeige auf PubMed

  • 28. Juni 2017 - BMC Public Health
    Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U
    Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.
    Zeige auf PubMed

  • 23. Juni 2017 - Cell Death Dis
    Gatliff J, East DA, Singh A, Alvarez MS, Frison M, Matic I, Ferraina C, Sampson N, Turkheimer F, Campanella M
    A role for TSPO in mitochondrial Ca<sup>2+</sup> homeostasis and redox stress signaling.
    Zeige auf PubMed

  • 22. Juni 2017 - Methods Mol Biol
    Eder T, Eder IE
    3D Hanging Drop Culture to Establish Prostate Cancer Organoids.
    Zeige auf PubMed
    Zum pdf

  • 20. Juni 2017 - Radiology
    Auer T, De Zordo T, Dejaco C, Gruber L, Pichler R, Jaschke W, Dogra VS, Aigner F
    Value of Multiparametric US in the Assessment of Intratesticular Lesions.
    Zeige auf PubMed

  • 08. Juni 2017 - Eur J Nucl Med Mol Imaging
    Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ
    Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
    Zeige auf PubMed
    Zum pdf

  • 13. Juni 2017 - Eur Urol
    Heidegger I, Pichler R, Pircher A
    Re: Erik Bovinder Ylitalo, Elin Thysell, Emma Jernberg, et al. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. Eur Urol 2017;71:776-87.
    Zeige auf PubMed

  • 30. Mai 2017 - Oncogenesis
    Nappo G, Handle F, Santer FR, McNeill RV, Seed RI, Collins AT, Morrone G, Culig Z, Maitland NJ, Erb HHH
    The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.
    Zeige auf PubMed

  • 18. Mai 2017 - Urol Int
    Heidegger I, Porres D, Veek N, Heidenreich A, Pfister D
    Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
    Zeige auf PubMed

  • 03. Mai 2017 - J Pediatr Urol
    Silay MS, Undre S, Nambiar AK, Dogan HS, Kocvara R, Nijman RJM, Stein R, Tekgul S, Radmayr C
    Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel.
    Zeige auf PubMed

  • 25. April 2017 - Clin Genitourin Cancer
    Pichler R, Tulchiner G, Oberaigner W, Schaefer G, Horninger W, Brunner A, Heidegger I
    Effect of Urinary Cytology for Detecting Recurrence in Remnant Urothelium After Radical Cystectomy: Insights From a 10-year Cytology Database.
    Zeige auf PubMed

  • 26. März 2017 - J Pediatr Urol
    Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S
    Corrigendum to "Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines" [J Pediatr Urol 12 (2016) 335-343].
    Zeige auf PubMed

  • 22. März 2017 - Prostate Cancer Prostatic Dis
    Heidegger I, Klocker H, Pichler R, Pircher A, Prokop W, Steiner E, Ladurner C, Comploj E, Lunacek A, Djordjevic D, Pycha A, Plas E, Horninger W, Bektic J
    ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.
    Zeige auf PubMed

  • 20. März 2017 - Mol Cell Endocrinol
    Culig Z, Puhr M
    Interleukin-6 and prostate cancer: Current developments and unsolved questions.
    Zeige auf PubMed

  • 01. Februar 2017 - Eur J Nucl Med Mol Imaging
    Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ
    <sup>68</sup>Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
    Zeige auf PubMed
    Zum pdf

  • 31. Jänner 2017 - Mol Oncol
    Hanrahan K, O'Neill A, Prencipe M, Bugler J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K, Watson RW
    The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 21. Jänner 2017 - Cancer Sci
    Pichler R, Fritz J, Heidegger I, Steiner E, Culig Z, Klocker H, Fuchs D
    Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 16. Jänner 2017
    Horninger, W. Therapieplanung und Therapieüberwachung. In: F. Aigner and L. Pallwein-Pretter (eds.),Prostata - Multimodale Bildgebung, 1. Auflage, Horn, Austria, Breitenseher Publisher, 2016.

  • 14. Jänner 2017 - Eur J Nucl Med Mol Imaging
    Scarpa L, Buxbaum S, Kendler D, Fink K, Bektic J, Gruber L, Decristoforo C, Uprimny C, Lukas P, Horninger W, Virgolini I
    The <sup>68</sup>Ga/<sup>177</sup>Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUV<sub>max</sub> values and absorbed dose estimates.
    Zeige auf PubMed
    Zum pdf

  • 23. Dezember 2016 - Cancer Immunol Immunother
    Pichler R, Gruenbacher G, Culig Z, Brunner A, Fuchs D, Fritz J, Gander H, Rahm A, Thurnher M
    Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
    Zeige auf PubMed
    Zum pdf

  • 14. Dezember 2016 - Urol Oncol
    Heidegger I, Oberaigner W, Horninger W, Pichler R
    High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
    Zeige auf PubMed
    Zum pdf

  • 01. Dezember 2016 - Eur J Nucl Med Mol Imaging
    Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, Roig LG, Kendler D, von Guggenberg E, Bektic J, Horninger W, Virgolini IJ
    Early dynamic imaging in <sup>68</sup>Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
    Zeige auf PubMed
    Zum pdf

  • 29. November 2016 - J Mol Biochem
    Ketola K, Viitala M, Kohonen P, Fey V, Culig Z, Kallioniemi O, Iljin K
    High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 19. November 2016 - BJU Int
    Bauer RM, Grabbert MT, Klehr B, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Kretschmer A
    36-month data for the AdVance XP<sup>®</sup> male sling: results of a prospective multicentre study.
    Zeige auf PubMed
    Zum pdf

  • 15. Oktober 2016 - Eur J Med Res
    Heidegger I, Tulchiner G, Schäfer G, Horninger W, Pichler R
    Long term disease free survival with multimodal therapy in small cell bladder cancer.
    Zeige auf PubMed
    Zum pdf

  • 01. Oktober 2016 - J Pediatr Urol
    Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S
    Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines.
    Zeige auf PubMed
    Zum pdf

  • 08. September 2016 - Clin Genitourin Cancer
    Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C
    Pelvic Lymph Node Staging by Combined <sup>18</sup>F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Zeige auf PubMed
    Zum pdf

  • 07. September 2016 - Int J Mol Sci
    Eder T, Weber A, Neuwirt H, Grünbacher G, Ploner C, Klocker H, Sampson N, Eder IE
    Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.
    Zeige auf PubMed
    Zum pdf

  • 20. August 2016 - Oncotarget
    Ippolito L, Marini A, Cavallini L, Morandi A, Pietrovito L, Pintus G, Giannoni E, Schrader T, Puhr M, Chiarugi P, Taddei ML
    Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
    Zeige auf PubMed
    Zum pdf

  • 12. August 2016 - World J Urol
    Auer T, Edlinger M, Bektic J, Nagele U, Herrmann T, Schäfer G, Aigner F, Junker D
    Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.
    Zeige auf PubMed
    Zum pdf

  • 04. August 2016 - Oncotarget
    Hoefer J, Akbor M, Handle F, Ofer P, Puhr M, Parson W, Culig Z, Klocker H, Heidegger I
    Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.
    Zeige auf PubMed
    Zum pdf

  • 25. Juli 2016 - Clin Genitourin Cancer
    Pichler R, Tulchiner G, Aigner F, Horninger W, Heidegger I
    Paratesticular Metastasis of a Clear-Cell Renal-Cell Carcinoma With Renal Vein Thrombus Mimicking Primary Testicular Cancer.
    Zeige auf PubMed
    Zum pdf

  • 28. Juli 2016 - Expert Opin Drug Saf
    Pinggera GM, Frauscher F
    Do we really need herbal medicine in LUTS/BPH treatment in the 21<sup>st</sup> century?
    Zeige auf PubMed
    Zum pdf

  • 21. Juli 2016 - Oncotarget
    Castelo-Branco P, Leão R, Lipman T, Campbell B, Lee D, Price A, Zhang C, Heidari A, Stephens D, Boerno S, Coelho H, Gomes A, Domingos C, Apolonio JD, Schäfer G, Bristow RG, Schweiger MR, Hamilton R, Zlotta A, Figueiredo A, Klocker H, Sültmann H, Tabori U
    A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.
    Zeige auf PubMed
    Zum pdf

  • 20. Juli 2016 - J Pediatr Urol
    Haid B, Strasser C, Becker T, Koen M, Berger C, Roesch J, Stuehmeier J, Schlenck B, Horninger W, Oswald J
    Evaluation of Mathisen's technique for ureteral reimplantation in children with primary vesicoureteral reflux.
    Zeige auf PubMed
    Zum pdf

  • 13. Juli 2016 - Eur Urol
    Culig Z
    STAT3 in Prostate Cancer: Whom Should We Treat and When?
    Zeige auf PubMed
    Zum pdf

  • 29. Juni 2016 - Cytokine
    Pencik J, Pham HT, Schmoellerl J, Javaheri T, Schlederer M, Culig Z, Merkel O, Moriggl R, Grebien F, Kenner L
    JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Zeige auf PubMed
    Zum pdf

  • 28. Juni 2016 - Cell Rep
    Gruenbacher G, Gander H, Rahm A, Idzko M, Nussbaumer O, Thurnher M
    Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens.
    Zeige auf PubMed
    Zum pdf

  • 25. Juni 2016 - Cell Chem Biol
    Thurnher M
    Small Drops Get Fat: Unexpected Fatty Acid in Cytoplasmic Lipid Droplets.
    Zeige auf PubMed
    Zum pdf

  • 17. Juni 2016 - Mol Cell Oncol
    Culig Z, Pencik J, Merkel O, Kenner L
    Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression.
    Zeige auf PubMed
    Zum pdf

  • 04. Juni 2016 - Endocr Relat Cancer
    Luef B, Handle F, Kharaishvili G, Hager M, Rainer J, Janetschek G, Hruby S, Englberger C, Bouchal J, Santer FR, Culig Z
    The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.
    Zeige auf PubMed
    Zum pdf

  • 27. Mai 2016 - Oncoscience
    Boesch M, Zeimet AG, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D
    High prevalence of side population in human cancer cell lines.
    Zeige auf PubMed

  • 26. Mai 2016 - Oncotarget
    Pichler R, Fritz J, Zavadil C, Schäfer G, Culig Z, Brunner A
    Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
    Zeige auf PubMed
    Zum pdf

  • 11. Mai 2016 - Endocrinology
    Jia B, Gao Y, Li M, Shi J, Peng Y, Du X, Klocker H, Sampson N, Shen Y, Liu M, Zhang J
    GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling Pathway.
    Zeige auf PubMed

  • 17. April 2016 - Nucleic Acids Res
    Weissensteiner H, Forer L, Fuchsberger C, Schöpf B, Kloss-Brandstätter A, Specht G, Kronenberg F, Schönherr S
    mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud.
    Zeige auf PubMed
    Zum pdf

  • 10. April 2016 - FEBS J
    Schöpf B, Schäfer G, Weber A, Talasz H, Eder IE, Klocker H, Gnaiger E
    Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells.
    Zeige auf PubMed

  • 08. April 2016 - Mol Cancer Res
    Handle F, Erb HH, Luef B, Hoefer J, Dietrich D, Parson W, Kristiansen G, Santer FR, Culig Z
    SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.
    Zeige auf PubMed
    Zum pdf

  • 07. April 2016 - Rofo
    Auer T, De Zordo T, Horninger W, Jaschke W, Aigner F
    [Multiparametric US of the Testicles--Selected Cases].
    Zeige auf PubMed
    Zum pdf

  • 30. März 2016 - Adv Urol
    Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B
    Hypothesis That Urethral Bulb (Corpus Spongiosum) Plays an Active Role in Male Urinary Continence.
    Zeige auf PubMed
    Zum pdf

  • 19. März 2016 - Mol Oncol
    Kurfurstova D, Bartkova J, Vrtel R, Mickova A, Burdova A, Majera D, Mistrik M, Kral M, Santer FR, Bouchal J, Bartek J
    DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 10. März 2016 - Oncotarget
    Pircher A, Jöhrer K, Kocher F, Steiner N, Graziadei I, Heidegger I, Pichler R, Leonhartsberger N, Kremser C, Kern J, Untergasser G, Gunsilius E, Hilbe W
    Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
    Zeige auf PubMed
    Zum pdf

  • 13. März 2016 - BJU Int
    Culig Z
    New possibilities for urinary molecular diagnostics.
    Zeige auf PubMed
    Zum pdf

  • 08. April 2016 - Mol Cancer Res
    Handle F, Erb HH, Luef B, Hoefer J, Dietrich D, Parson W, Kristiansen G, Santer FR, Culig Z
    SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.
    Zeige auf PubMed
    Zum pdf

  • 17. Oktober 2015 - Urologe A
    Pichler R, Horninger W, Aigner F, Heidegger I
    [Bevacizumab as first-line therapy in metastatic renal cell carcinoma: Progression-free survival for 3 years].
    Zeige auf PubMed
    Zum pdf

  • 30. März 2016 - Adv Urol
    Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B
    Hypothesis That Urethral Bulb (Corpus Spongiosum) Plays an Active Role in Male Urinary Continence.
    Zeige auf PubMed
    Zum pdf

  • 11. Februar 2016 - PLoS One
    Schlick B, Massoner P, Lueking A, Charoentong P, Blattner M, Schaefer G, Marquart K, Theek C, Amersdorfer P, Zielinski D, Kirchner M, Trajanoski Z, Rubin MA, Müllner S, Schulz-Knappe P, Klocker H
    Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.
    Zeige auf PubMed
    Zum pdf

  • 03. Februar 2016 - Wien Klin Wochenschr
    Ponholzer A, Loidl W, Bektic J, Dorfinger K, Hruby S, Jeschke K, Kramer G, Krause S, Ludvik G, Remzi M, Roider M, Stoiber F
    Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. Jänner 2016 - BMJ Open
    Schönherr E, Rehwald R, Nasseri P, Luger AK, Grams AE, Kerschbaum J, Rehder P, Petersen J, Glodny B
    Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria.
    Zeige auf PubMed
    Zum pdf

  • 23. Dezember 2015 - Swiss Med Wkly
    Pencik J, Wiebringhaus R, Susani M, Culig Z, Kenner L
    IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 20. November 2015 - World J Urol
    Bauer RM, Gozzi C, Klehr B, Kretschmer A, Grabbert M, Rehder P, May F, Stief CG, Gebhartl P, Homberg R
    AdVanceXP male sling: 2-year results of a multicentre study.
    Zeige auf PubMed
    Zum pdf

  • 17. November 2015 - Urol Int
    Heidegger I, Fritz J, Steiner H, Bektic J, Pichler R
    Hydronephrosis Predicts Successful Catheter Removal after Painful Urinary Retention - Preliminary Results of a Prospective Single Center Study.
    Zeige auf PubMed
    Zum pdf

  • 21. Oktober 2015 - Endocr Relat Cancer
    Kroon J, Puhr M, Buijs JT, van der Horst G, Hemmer DM, Marijt KA, Hwang MS, Masood M, Grimm S, Storm G, Metselaar JM, Meijer OC, Culig Z, van der Pluijm G
    Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 17. Oktober 2015 - Urologe A
    Pichler R, Horninger W, Aigner F, Heidegger I
    [Bevacizumab as first-line therapy in metastatic renal cell carcinoma: Progression-free survival for 3 years].
    Zeige auf PubMed

  • 10. Oktober 2015 - Mol Endocrinol
    Ofer P, Heidegger I, Eder IE, Schöpf B, Neuwirt H, Geley S, Klocker H, Massoner P
    Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Zeige auf PubMed
    Zum pdf

  • 30. September 2015 - Oncotarget
    Slabáková E, Kharaishvili G, Smějová M, Pernicová Z, Suchánková T, Remšík J, Lerch S, Straková N, Bouchal J, Král M, Culig Z, Kozubík A, Souček K
    Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
    Zeige auf PubMed
    Zum pdf

  • 29. September 2015 - Hum Mutat
    Bu H, Narisu N, Schlick B, Rainer J, Manke T, Schäfer G, Pasqualini L, Chines P, Schweiger MR, Fuchsberger C, Klocker H
    Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.
    Zeige auf PubMed
    Zum pdf

  • 02. September 2015 - Oncotarget
    Perner S, Cronauer MV, Schrader AJ, Klocker H, Culig Z, Baniahmad A
    Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 27. August 2015 - Prostate
    Heidegger I, Höfer J, Luger M, Pichler R, Klocker H, Horninger W, Steiner E, Jochberger S, Culig Z
    Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?
    Zeige auf PubMed
    Zum pdf

  • 20. August 2015
    Semin Cancer Biol.

  • 19. August 2015 - PLoS One
    Dueregger A, Schöpf B, Eder T, Höfer J, Gnaiger E, Aufinger A, Kenner L, Perktold B, Ramoner R, Klocker H, Eder IE
    Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.
    Zeige auf PubMed

  • 12. Juni 2015 - Stud Health Technol Inform
    Hofer P, Neururer S, Hauffe H, Insam T, Zeilner A, Göbel G
    Semi-automated evaluation of biomedical ontologies for the biobanking domain based on competency questions.
    Zeige auf PubMed
    Zum pdf

  • 12. August 2015 - PLoS One
    Kloss-Brandstätter A, Weissensteiner H, Erhart G, Schäfer G, Forer L, Schönherr S, Pacher D, Seifarth C, Stöckl A, Fendt L, Sottsas I, Klocker H, Huck CW, Rasse M, Kronenberg F, Kloss FR
    Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 11. August 2015 - Oncogene
    Puhr M, Hoefer J, Eigentler A, Dietrich D, van Leenders G, Uhl B, Hoogland M, Handle F, Schlick B, Neuwirt H, Sailer V, Kristiansen G, Klocker H, Culig Z
    PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 02. August 2015 - Cancer Lett
    Heidegger I, Massoner P, Sampson N, Klocker H
    The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 29. Juli 2015 - PLoS One
    Heidegger I, Fritz J, Klocker H, Pichler R, Bektic J, Horninger W
    Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.
    Zeige auf PubMed
    Zum pdf

  • 24. Juli 2015 - J Cell Physiol
    Culig Z
    Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 02. Juli 2015 - World J Urol
    Junker D, Herrmann TR, Bader M, Bektic J, Henkel G, Kruck S, Sandbichler M, Schilling D, Schäfer G, Nagele U, Training Research in Urological Surgery Therapy (T.R.U.S.T.) group.
    Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).
    Zeige auf PubMed
    Zum pdf

  • 09. Juni 2015 - Mol Endocrinol
    Pasqualini L, Bu H, Puhr M, Narisu N, Rainer J, Schlick B, Schäfer G, Angelova M, Trajanoski Z, Börno ST, Schweiger MR, Fuchsberger C, Klocker H
    miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 31. Mai 2015 - Anticancer Res
    Heidegger I, Klocker H, Pichler R, Horninger W, Bektic J
    PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer.
    Zeige auf PubMed
    Zum pdf

  • 16. Mai 2015 - Med Decis Making
    Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U
    The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening.
    Zeige auf PubMed
    Zum pdf

  • 16. Mai 2015 - Eur J Nucl Med Mol Imaging
    Ceci F, Uprimny C, Nilica B, Geraldo L, Kendler D, Kroiss A, Bektic J, Horninger W, Lukas P, Decristoforo C, Castellucci P, Fanti S, Virgolini IJ
    (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
    Zeige auf PubMed
    Zum pdf

  • 13. Mai 2015 - Anticancer Res
    Heidegger I, Borena W, Pichler R
    The role of human papilloma virus in urological malignancies.
    Zeige auf PubMed
    Zum pdf

  • 16. April 2015 - EMBO Mol Med
    Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, Lübbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, Küsters S, Hopt UT, Stemmler MP, Brabletz T
    ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
    Zeige auf PubMed
    Zum pdf

  • 02. April 2015 - Sci Signal
    Thurnher M, Gruenbacher G
    T lymphocyte regulation by mevalonate metabolism.
    Zeige auf PubMed
    Zum pdf

  • 25. März 2015 - Biomed Res Int
    Herwig R, Sansalone S, Rehder P
    Genitourethral reconstruction.
    Zeige auf PubMed
    Zum pdf

  • 20. März 2015 - World J Urol
    Pichler R, Borena W, Schäfer G, Manzl C, Culig Z, List S, Neururer S, Von Laer D, Heidegger I, Klocker H, Horninger W, Steiner H, Brunner A
    Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.
    Zeige auf PubMed
    Zum pdf

  • 10. März 2015 - Oncotarget
    Santer FR, Erb HH, Oh SJ, Handle F, Feiersinger GE, Luef B, Bu H, Schäfer G, Ploner C, Egger M, Rane JK, Maitland NJ, Klocker H, Eder IE, Culig Z
    Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.
    Zeige auf PubMed
    Zum pdf

  • 06. März 2015
    C. Radmayr, C. Congenital obstructive uropathy - Diagnostics for optimal treatment. Afr J Urol 21:87-95, 2015.

  • 14. Februar 2015 - PLoS One
    Neuwirt H, Wabnig E, Feistritzer C, Eder IE, Salvador C, Puhr M, Culig Z, Massoner P, Tiefenthaler M, Steurer M, Konwalinka G
    Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.
    Zeige auf PubMed
    Zum pdf

  • 10. Februar 2015 - Urol Int
    Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W
    Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck.
    Zeige auf PubMed
    Zum pdf

  • 07. Februar 2015 - PLoS One
    Heidegger I, Skradski V, Steiner E, Klocker H, Pichler R, Pircher A, Horninger W, Bektic J
    High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance.
    Zeige auf PubMed
    Zum pdf

  • 17. Jänner 2015 - Urol Int
    Junker D, Schäfer G, Heidegger I, Bektic J, Ladurner M, Jaschke W, Aigner F
    Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Zeige auf PubMed
    Zum pdf

  • 07. Jänner 2015 - Mol Carcinog
    Höll M, Koziel R, Schäfer G, Pircher H, Pauck A, Hermann M, Klocker H, Jansen-Dürr P, Sampson N
    ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
    Zeige auf PubMed
    Zum pdf

  • 28. Dezember 2014 - Jpn J Clin Oncol
    Pircher A, Gastl G, Heidegger I
    Ulcerative skin metastases of primary lung cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. Dezember 2014 - Eur Urol
    Stein R, Dogan HS, Hoebeke P, Kočvara R, Nijman RJ, Radmayr C, Tekgül S, European Association of Urology., European Society for Pediatric Urology.
    Urinary tract infections in children: EAU/ESPU guidelines.
    Zeige auf PubMed
    Zum pdf

  • 05. Dezember 2014 - Oncotarget
    Puhr M, Hoefer J, Neuwirt H, Eder IE, Kern J, Schäfer G, Geley S, Heidegger I, Klocker H, Culig Z
    PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells.
    Zeige auf PubMed
    Zum pdf

  • 03. Dezember 2014 - J Urol
    Culig Z
    Epithelial-to-mesenchymal transition in a virally induced cancer.
    Zeige auf PubMed
    Zum pdf

  • 28. Jänner 2016 - Transl Androl Urol
    Kaya C, Radmayr C
    The role of pre-operative androgen stimulation in hypospadias surgery.
    Zeige auf PubMed
    Zum pdf

  • 07. November 2014 - Biomed Res Int
    Haubner R, Maschauer S, Einsiedel J, Eder IE, Rangger C, Gmeiner P, Virgolini IJ, Prante O
    H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?
    Zeige auf PubMed
    Zum pdf

  • 07. November 2014 - Am J Clin Exp Urol
    Culig Z
    Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.
    Zeige auf PubMed
    Zum pdf

  • 23. Oktober 2014 - Nutrients
    Dueregger A, Heidegger I, Ofer P, Perktold B, Ramoner R, Klocker H, Eder IE
    The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.
    Zeige auf PubMed
    Zum pdf

  • 23. Oktober 2013 - World J Urol
    Heidegger I, Pichler R, Müller B, Klocker H, Oswald D, Haid B, Zelger B, Horninger W, Oswald J
    Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
    Zeige auf PubMed
    Zum pdf

  • 09. Oktober 2014 - Eur J Nucl Med Mol Imaging
    Uprimny C, Kroiss A, Nilica B, Buxbaum S, Decristoforo C, Horninger W, Virgolini IJ
    (68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.
    Zeige auf PubMed
    Zum pdf

  • 05. Oktober 2014 - Lancet Oncol
    Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, Ilic D, Key TJ, La Vecchia C, Lilja H, Marberger M, Meyskens FL, Minasian LM, Parker C, Parnes HL, Perner S, Rittenhouse H, Schalken J, Schmid HP, Schmitz-Dräger BJ, Schröder FH, Stenzl A, Tombal B, Wilt TJ, Wolk A
    Prevention and early detection of prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 27. September 2014 - Case Rep Urol
    Rehder P, Schillfahrt F, Skradski V
    Surgical reconstruction of the urinary sphincter after traumatic longitudinal disruption.
    Zeige auf PubMed
    Zum pdf

  • 20. September 2014 - Oncotarget
    Neeb A, Hefele S, Bormann S, Parson W, Adams F, Wolf P, Miernik A, Schoenthaler M, Kroenig M, Wilhelm K, Schultze-Seemann W, Nestel S, Schaefer G, Bu H, Klocker H, Nazarenko I, Cato AC
    Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 28. August 2014 - Stud Health Technol Inform
    Hofer P, Fiegl H, Angerer J, Mueller-Holzner E, Chamson M, Klocker H, Steiner E, Hauffe H, Zschocke J, Goebel G
    A concept of a MIABIS based register of biosample collections at the Medical University of Innsbruck.
    Zeige auf PubMed
    Zum pdf

  • 21. August 2014 - Cent European J Urol
    Lunacek A, Radmayr C, Horninger W, Plas E
    Pfannenstiel incision for radical retropubic prostatectomy as a surgical and cosmetic alternative to the midline or laparoscopic approach: A single center study.
    Zeige auf PubMed
    Zum pdf

  • 14. August 2014 - Urol Int
    Pichler R, Heidegger I, Aigner F, Bösmüller C, Schneeberger S, Maglione M, Schäfer G, Steiner H, Horninger W
    De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound.
    Zeige auf PubMed
    Zum pdf

  • 08. August 2014 - Int J Urol
    Lunacek A, Mrstik C, Simon J, Frauscher F, Schwentner C, Radmayr C, Horninger W, Plas E
    Response to Editorial Comment to Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: a prospective randomized trial.
    Zeige auf PubMed
    Zum pdf

  • 05. August 2014 - Clin Genitourin Cancer
    Pichler R, Heidegger I, Brunner A, Steiner H
    Long-term follow-up of a primary teratoma with somatic-type malignancy within the thyroid gland mimicking thyroid carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 02. August 2014 - World J Urol
    Junker D, Quentin M, Nagele U, Edlinger M, Richenberg J, Schaefer G, Ladurner M, Jaschke W, Horninger W, Aigner F
    Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis.
    Zeige auf PubMed
    Zum pdf

  • 04. Juli 2014 - Br J Cancer
    Massoner P, Thomm T, Mack B, Untergasser G, Martowicz A, Bobowski K, Klocker H, Gires O, Puhr M
    EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
    Zeige auf PubMed
    Zum pdf

  • 01. Juli 2014 - Int J Urol
    Lunacek A, Mrstik C, Simon J, Frauscher F, Schwentner C, Radmayr C, Horninger W, Plas E
    Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: a prospective randomized trial.
    Zeige auf PubMed
    Zum pdf

  • 28. Juni 2014 - Urol Int
    Comploj E, West J, Mian M, Kluth LA, Karl A, Dechet C, Shariat SF, Stief CG, Trenti E, Palermo S, Lodde M, Horninger W, Madersbacher S, Pycha A
    Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
    Zeige auf PubMed
    Zum pdf

  • 27. Juni 2014 - Biomed Res Int
    Junker D, De Zordo T, Quentin M, Ladurner M, Bektic J, Horniger W, Jaschke W, Aigner F
    Real-time elastography of the prostate.
    Zeige auf PubMed
    Zum pdf

  • 19. Juni 2014 - Urology
    Pinggera GM, Frauscher F, Paduch DA, Bolyakov A, Efros M, Kaminetsky J, Da Pozzo L, Esler A, Cox D
    Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
    Zeige auf PubMed
    Zum pdf

  • 11. Juni 2014 - Mol Cancer
    Köhler A, Demir U, Kickstein E, Krauss S, Aigner J, Aranda-Orgillés B, Karagiannidis AI, Achmüller C, Bu H, Wunderlich A, Schweiger MR, Schaefer G, Schweiger S, Klocker H, Schneider R
    A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.
    Zeige auf PubMed
    Zum pdf

  • 04. Juni 2014 - Expert Opin Pharmacother
    Culig Z
    Targeting the androgen receptor in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 29. Mai 2014 - Korean J Urol
    Lunacek A, Koenig U, Mrstik C, Radmayr C, Horninger W, Plas E
    Unexpected Multidrug Resistance of Methicillin-Resistant Staphylococcus aureus in Urine Samples: A Single-Center Study.
    Zeige auf PubMed
    Zum pdf

  • 10. Mai 2014 - Oncotarget
    Heidegger I, Kern J, Ofer P, Klocker H, Massoner P
    Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
    Zeige auf PubMed
    Zum pdf

  • 29. April 2014 - Eur Urol
    Culig Z
    TMPRSS:ERG fusion in prostate cancer: from experimental approaches to prognostic studies.
    Zeige auf PubMed
    Zum pdf

  • 25. April 2014 - Endocrine
    Ning Z, Du X, Zhang J, Yang K, Miao L, Zhu Y, Yuan H, Wang L, Klocker H, Shi J
    PGE2 modulates the transcriptional activity of ERRa in prostate stromal cells.
    Zeige auf PubMed
    Zum pdf

  • 23. April 2014 - Prostate
    Shao R, Shi J, Liu H, Shi X, Du X, Klocker H, Lee C, Zhu Y, Zhang J
    Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Zeige auf PubMed
    Zum pdf

  • 05. April 2014 - Biomed Res Int
    Sampson N, Berger P, Zenzmaier C
    Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
    Zeige auf PubMed
    Zum pdf

  • 01. April 2014 - Scand J Urol
    Pichler R, Heidegger I, Schlenck B, Horninger W, Oswald J
    Clinical outcome after endoscopic therapy for occult vesicoureteral reflux in females: preliminary results of a retrospective case series.
    Zeige auf PubMed

  • 22. März 2014 - Int J Urol
    Heidegger I, Pichler R, Schäfer G, Zelger B, Zelger B, Aigner F, Bektic J, Horninger W
    Long-term follow up of renal anastomosing hemangioma mimicking renal angiosarcoma.
    Zeige auf PubMed
    Zum pdf

  • 21. März 2014 - Eur Urol
    Culig Z
    Words of wisdom: Re: TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.
    Zeige auf PubMed
    Zum pdf

  • 21. März 2014 - Eur Urol
    Culig Z
    Words of wisdom: Re: Lin28 promotes growth of prostate cancer cells and activates the androgen receptor.
    Zeige auf PubMed
    Zum pdf

  • 26. Februar 2014 - Eur Urol
    Sampson N, Berger P, Klocker H
    Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers. Eur Urol 2013;64:941-50.
    Zeige auf PubMed
    Zum pdf

  • 25. Februar 2014 - Urology
    Leonhartsberger N, Pichler R, Stoehr B, Horninger W, Steiner H
    Organ preservation technique without ischemia in patients with testicular tumor.
    Zeige auf PubMed
    Zum pdf

  • 22. Februar 2014 - AJR Am J Roentgenol
    Junker D, Schäfer G, Kobel C, Kremser C, Bektic J, Jaschke W, Aigner F
    Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis.
    Zeige auf PubMed
    Zum pdf

  • 18. Februar 2014 - Recent Results Cancer Res
    Culig Z
    Distinguishing indolent from aggressive prostate cancer.
    Zeige auf PubMed

  • 04. Februar 2014 - BMC Cancer
    Demir U, Koehler A, Schneider R, Schweiger S, Klocker H
    Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.
    Zeige auf PubMed
    Zum pdf

  • 29. Jänner 2014 - Cancer Lett
    Gruenbacher G, Thurnher M
    Mevalonate metabolism in cancer.
    Zeige auf PubMed
    Zum pdf

  • 10. Jänner 2014 - Anticancer Res
    Heidegger I, Nagele U, Pircher A, Pichler R, Horninger W, Bektic J
    Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy.
    Zeige auf PubMed
    Zum pdf

  • 10. Jänner 2014 - Oncology
    Pircher A, Wellbrock J, Fiedler W, Heidegger I, Gunsilius E, Hilbe W
    New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.
    Zeige auf PubMed
    Zum pdf

  • 08. Jänner 2014 - Biomed Res Int
    Junker D, Schäfer G, Edlinger M, Kremser C, Bektic J, Horninger W, Jaschke W, Aigner F
    Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 04. Jänner 2014 - Cancer Metastasis Rev
    Culig Z, Santer FR
    Androgen receptor signaling in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 04. Dezember 2013 - Urology
    Oswald J, Heidegger I, Steiner E, Brenner E, Ladurner Rennau M, Pichler R, Becker T, Loidl W, Horninger W, Fritsch H
    Gender-related fetal development of the internal urethral sphincter.
    Zeige auf PubMed

  • 28. November 2013 - Endocr Relat Cancer
    Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M
    SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
    Zeige auf PubMed

  • 30. Oktober 2013 - World J Urol
    Comploj E, Dechet CB, Mian M, Trenti E, Palermo S, Lodde M, Mian C, Ambrosini-Spaltro A, Horninger W, Pycha A
    Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer.
    Zeige auf PubMed

  • 30. Oktober 2013 - Prostate Cancer Prostatic Dis
    Heidegger I, Klocker H, Steiner E, Skradski V, Ladurner M, Pichler R, Schäfer G, Horninger W, Bektic J
    [-2]proPSA is an early marker for prostate cancer aggressiveness.
    Zeige auf PubMed

  • 16. Jänner 2014 - Cancer Metastasis Rev
    Augello MA, Den RB, Knudsen KE
    AR function in promoting metastatic prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 23. Oktober 2013 - World J Urol
    Heidegger I, Pichler R, Müller B, Klocker H, Oswald D, Haid B, Zelger B, Horninger W, Oswald J
    Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
    Zeige auf PubMed

  • 05. Oktober 2013 - World J Urol
    Leonhartsberger N, Pichler R, Stoehr B, Horninger W, Steiner H
    Organ-sparing surgery is the treatment of choice in benign testicular tumors.
    Zeige auf PubMed
    Zum pdf

  • 18. September 2013 - Biomed Tech (Berl)
    Popovscaia M, Baumgartner C, Handler M, Klocker H
    Identifying Biologically Meaningful Groups of Genes in the Androgen Receptor Network.
    Zeige auf PubMed
    Zum pdf

  • 27. August 2013 - Phytomedicine
    Dueregger A, Guggenberger F, Barthelmes J, Stecher G, Schuh M, Intelmann D, Abel G, Haunschild J, Klocker H, Ramoner R, Sampson N
    Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055.
    Zeige auf PubMed
    Zum pdf

  • 20. August 2013 - J Proteomics
    Pallua JD, Schaefer G, Seifarth C, Becker M, Meding S, Rauser S, Walch A, Handler M, Netzer M, Popovscaia M, Osl M, Baumgartner C, Lindner H, Kremser L, Sarg B, Bartsch G, Huck CW, Bonn GK, Klocker H
    MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. August 2013 - Endocr Relat Cancer
    Erb HH, Langlechner RV, Moser PL, Handle F, Casneuf T, Verstraeten K, Schlick B, Schäfer G, Hall B, Sasser K, Culig Z, Santer FR
    IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.
    Zeige auf PubMed
    Zum pdf

  • 25. Juni 2013 - J Immunol
    Nussbaumer O, Gruenbacher G, Gander H, Komuczki J, Rahm A, Thurnher M
    Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
    Zeige auf PubMed
    Zum pdf
    Kurzinformation

  • 25. Juni 2013 - J Steroid Biochem Mol Biol
    Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H
    Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 14. Juni 2013 - Eur Urol
    Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Grönberg H, Luo J, Visakorpi T, Rubin MA
    The mutational landscape of prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. Juni 2013 - Urol Int
    Pichler R, Heidegger I, Klinglmair G, Kroiss A, Uprimny C, Gasser RW, Schäfer G, Steiner H
    Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine.
    Zeige auf PubMed
    Zum pdf

  • 06. Juni 2013 - Int J Mol Sci
    Eder IE, Egger M, Neuwirt H, Seifarth C, Maddalo D, Desiniotis A, Schäfer G, Puhr M, Bektic J, Cato AC, Klocker H
    Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo.
    Zeige auf PubMed
    Zum pdf

  • 18. Mai 2013 - Tech Coloproctol
    Plaikner M, Loizides A, Peer S, Aigner F, Pecival D, Zbar A, Kremser C, Gruber H
    Transperineal ultrasonography as a complementary diagnostic tool in identifying acute perianal sepsis.
    Zeige auf PubMed
    Zum pdf

  • 07. Mai 2013 - Steroids
    Culig Z, Santer FR
    Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 13. April 2013 - Endocr Relat Cancer
    Wu X, Gong S, Roy-Burman P, Lee P, Culig Z
    Current mouse and cell models in prostate cancer research.
    Zeige auf PubMed
    Zum pdf

  • 13. April 2013 - Fertil Steril
    Frühmesser A, Vogt PH, Zimmer J, Witsch-Baumgartner M, Fauth C, Zschocke J, Pinggera GM, Kotzot D
    Single nucleotide polymorphism array analysis in men with idiopathic azoospermia or oligoasthenozoospermia syndrome.
    Zeige auf PubMed
    Zum pdf

  • 05. April 2013 - Transfusion
    Gassner C, Utz I, Schennach H, Ramoni A, Steiner H, Scholz S, Kreklau U, Körmöczi GF
    Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.
    Zeige auf PubMed
    Zum pdf

  • 26. März 2013 - Biochim Biophys Acta
    Thurnher M, Gruenbacher G, Nussbaumer O
    Regulation of mevalonate metabolism in cancer and immune cells.
    Zeige auf PubMed
    Zum pdf
    Kurzinformation

  • 16. März 2013 - Cancer Cytopathol
    Comploj E, Mian C, Ambrosini-Spaltro A, Dechet C, Palermo S, Trenti E, Lodde M, Horninger W, Pycha A
    uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Zeige auf PubMed
    Zum pdf

  • 09. März 2013 - BJU Int
    Pichler R, Djedovic G, Klocker H, Heidegger I, Strasak A, Loidl W, Bektic J, Skradski V, Horninger W, Oswald J
    Quantitative measurement of the androgen receptor in prepuces of boys with and without hypospadias.
    Zeige auf PubMed
    Zum pdf


  • BMC CANCER

  • 01. März 2013 - Endocr Relat Cancer
    Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE
    In vitro model systems to study androgen receptor signaling in prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 08. Februar 2013 - PLoS One
    Massoner P, Kugler KG, Unterberger K, Kuner R, Mueller LA, Fälth M, Schäfer G, Seifarth C, Ecker S, Verdorfer I, Graber A, Sültmann H, Klocker H
    Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.
    Zeige auf PubMed
    Zum pdf

  • 06. Februar 2013 - Prostate Cancer Prostatic Dis
    Schaefer G, Mosquera JM, Ramoner R, Park K, Romanel A, Steiner E, Horninger W, Bektic J, Ladurner-Rennau M, Rubin MA, Demichelis F, Klocker H
    Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 30. Jänner 2013 - Prostate
    Prencipe M, Madden SF, O'Neill A, O'Hurley G, Culhane A, O'Connor D, Klocker H, Kay EW, Gallagher WM, Watson WR
    Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?
    Zeige auf PubMed
    Zum pdf

  • 23. Jänner 2013 - Nat Rev Urol
    De Zordo T, Stronegger D, Pallwein-Prettner L, Harvey CJ, Pinggera G, Jaschke W, Aigner F, Frauscher F
    Multiparametric ultrasonography of the testicles.
    Zeige auf PubMed
    Zum pdf

  • 11. Jänner 2013 - Scand J Urol
    Pichler R, Zangerl F, Leonhartsberger N, Stöhr B, Horninger W, Steiner H
    Orthotopic bladder replacement in women: focus on functional results of a retrospective, single-centre study.
    Zeige auf PubMed
    Zum pdf

  • 09. Jänner 2013 - Chemotherapy
    Pichler R, Leonhartsberger N, Stöhr B, Horninger W, Steiner H
    Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.
    Zeige auf PubMed
    Zum pdf

  • 09. Jänner 2013 - FEBS J
    Bu H, Schweiger MR, Manke T, Wunderlich A, Timmermann B, Kerick M, Pasqualini L, Shehu E, Fuchsberger C, Cato AC, Klocker H
    Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
    Zeige auf PubMed
    Zum pdf
    Kurzinformation

  • 02. Jänner 2013 - Front Biosci (Schol Ed)
    Culig Z
    Suppressors of cytokine signalling-3 and -1 in human carcinogenesis.
    Zeige auf PubMed
    Zum pdf

  • 19. Dezember 2012 - Int J Biochem Cell Biol
    Peng Y, Shi J, Du X, Wang L, Klocker H, Mo L, Mo Z, Zhang J
    Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Zeige auf PubMed
    Zum pdf

  • 15. Dezember 2012 - World J Urol
    Klinglmair G, Pichler R, Zelger B, Dogan HS, Becker T, Esterbauer J, Riccabona M, Loidl W, Horninger W, Oswald J
    Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men.
    Zeige auf PubMed
    Zum pdf

  • 11. Dezember 2012 - Anticancer Res
    Heidegger I, Ladurner M, Skradski V, Klocker H, Schäfer G, Horninger W, Bektic J
    Adverse pathological findings in needle biopsy gleason score 6 prostate cancers with low and intermediate preoperative PSA levels following radical prostatectomy.
    Zeige auf PubMed
    Zum pdf

  • 30. November 2012 - Endocr Relat Cancer
    Culig Z
    Rapidly changing endocrine oncology research: personal reflection of the past, present and future times.
    Zeige auf PubMed
    Zum pdf

  • 15. November 2012 - Oxid Med Cell Longev
    Sampson N, Berger P, Zenzmaier C
    Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.
    Zeige auf PubMed
    Zum pdf

  • 31. Oktober 2012 - Lab Invest
    Neuwirt H, Eder IE, Puhr M, Rudnicki M
    SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner.
    Zeige auf PubMed
    Zum pdf

  • 31. Oktober 2012 - BJU Int
    Stoehr B, Schachtner L, Pichler R, Holzner B, Giesinger J, Oberguggenberger A, Leonhartsberger N, Horninger W, Steiner H
    Influence of achieved paternity on quality of life in testicular cancer survivors.
    Zeige auf PubMed
    Zum pdf

  • 30. Oktober 2012 - Expert Opin Ther Targets
    Culig Z
    Interleukin-6 as a therapy target in oral squamous carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 09. Oktober 2012 - Am J Pathol
    Puhr M, Hoefer J, Schäfer G, Erb HH, Oh SJ, Klocker H, Heidegger I, Neuwirt H, Culig Z
    Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.
    Zeige auf PubMed
    Zum pdf

  • 15. September 2012 - Int J Exp Pathol
    Denzel S, Mack B, Eggert C, Massoner P, Stöcklein N, Kemming D, Harréus U, Gires O
    MMP7 is a target of the tumour-associated antigen EpCAM.
    Zeige auf PubMed
    Zum pdf

  • 06. September 2012 - Endocrinology
    Zenzmaier C, Kern J, Sampson N, Heitz M, Plas E, Untergasser G, Berger P
    Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
    Zeige auf PubMed
    Zum pdf

  • 21. August 2012 - Endocrinology
    Heidegger I, Ofer P, Doppler W, Rotter V, Klocker H, Massoner P
    Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells.
    Zeige auf PubMed
    Zum pdf
    Kurzinformation

  • 14. August 2012 - Am J Pathol
    Sampson N, Ruiz C, Zenzmaier C, Bubendorf L, Berger P
    PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 07. August 2012 - World J Urol
    Pichler R, Klima G, Richter E, Marksteiner R, Mayr V, Skradski V, Horninger W, Oswald J
    Autologous fibroblast transplantation at the vesico-ureteral junction as potential reconstructive cell replacement in an animal model.
    Zeige auf PubMed
    Zum pdf

  • 14. Juli 2012 - Analyst
    Pallua JD, Pezzei C, Zelger B, Schaefer G, Bittner LK, Huck-Pezzei VA, Schoenbichler SA, Hahn H, Kloss-Brandstaetter A, Kloss F, Bonn GK, Huck CW
    Fourier transform infrared imaging analysis in discrimination studies of squamous cell carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 25. April 2012 - Clin Cancer Res
    Thurnher M, Nussbaumer O, Gruenbacher G
    Novel aspects of mevalonate pathway inhibitors as antitumor agents.
    Zeige auf PubMed
    Zum pdf

  • 25. April 2012 - World J Urol
    Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, Thompson IM
    Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
    Zeige auf PubMed
    Zum pdf

  • 13. April 2012 - Proc Natl Acad Sci U S A
    Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA
    Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
    Zeige auf PubMed
    Zum pdf

  • 31. März 2012 - Mod Pathol
    Haffner MC, Laimer J, Chaux A, Schäfer G, Obrist P, Brunner A, Kronberger IE, Laimer K, Gurel B, Koller JB, Seifarth C, Zelger B, Klocker H, Rasse M, Doppler W, Bander NH
    High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
    Zeige auf PubMed
    Zum pdf

  • 28. März 2012 - Am J Pathol
    Hoefer J, Schäfer G, Klocker H, Erb HH, Mills IG, Hengst L, Puhr M, Culig Z
    PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.
    Zeige auf PubMed
    Zum pdf
    Kurzinformation

  • 22. März 2012 - Urol Int
    Pichler R, Fritsch H, Skradski V, Horninger W, Schlenck B, Rehder P, Oswald J
    Diagnosis and management of pediatric urethral injuries.
    Zeige auf PubMed
    Zum pdf

  • 13. März 2012 - Qual Life Res
    Holzner B, Efficace F, Basso U, Johnson CD, Aaronson NK, Arraras JI, Smith AB, Chow E, Oberguggenberger AS, Bottomley A, Steiner H, Incrocci L, Giesinger JM
    Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
    Zeige auf PubMed
    Zum pdf

  • 10. März 2012 - Reprod Fertil Dev
    Doyle U, Sampson N, Zenzmaier C, Schwärzler P, Berger P
    Seminal plasma enhances and accelerates progesterone-induced decidualisation of human endometrial stromal cells.
    Zeige auf PubMed
    Zum pdf

  • 08. März 2012 - Radiology
    Aigner F, De Zordo T, Pallwein-Prettner L, Junker D, Schäfer G, Pichler R, Leonhartsberger N, Pinggera G, Dogra VS, Frauscher F
    Real-time sonoelastography for the evaluation of testicular lesions.
    Zeige auf PubMed
    Zum pdf

  • 07. März 2012 - World J Urol
    Cronauer MV, Culig Z
    Molecular aspects of prostate cancer.
    Zeige auf PubMed
    Zum pdf

  • 06. März 2012 - Eur Urol
    Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM
    Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up.
    Zeige auf PubMed
    Zum pdf

  • 03. März 2012 - Endocr Relat Cancer
    Oh SJ, Erb HH, Hobisch A, Santer FR, Culig Z
    Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.
    Zeige auf PubMed
    Zum pdf

  • 04. Februar 2012 - Carcinogenesis
    Kong L, Schäfer G, Bu H, Zhang Y, Zhang Y, Klocker H
    Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway.
    Zeige auf PubMed
    Zum pdf

  • 27. Jänner 2012 - Cancer Immunol Immunother
    Leonhartsberger N, Ramoner R, Falkensammer C, Rahm A, Gander H, Höltl L, Thurnher M
    Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma.
    Zeige auf PubMed
    Zum pdf

  • 03. Jänner 2012 - World J Urol
    Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ
    Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
    Zeige auf PubMed
    Zum pdf

Universitätsklinik für Urologie - Labor | Abt. für Experimentelle Urologie | Anichstraße 35, 6020 Innsbruck
Tel.: +43 512 504 24874 | Fax.: +43 512 504 24817 | Email: lki.ur.labor@tirol-kliniken.at